Identification and annotation of 3' UTR ends using RNA-seq data

Information

  • Research Project
  • 8928579
  • ApplicationId
    8928579
  • Core Project Number
    R21CA187910
  • Full Project Number
    5R21CA187910-02
  • Serial Number
    187910
  • FOA Number
    PAR-13-146
  • Sub Project Id
  • Project Start Date
    9/17/2014 - 10 years ago
  • Project End Date
    8/31/2016 - 8 years ago
  • Program Officer Name
    LI, JERRY
  • Budget Start Date
    9/1/2015 - 9 years ago
  • Budget End Date
    8/31/2016 - 8 years ago
  • Fiscal Year
    2015
  • Support Year
    02
  • Suffix
  • Award Notice Date
    7/23/2015 - 9 years ago

Identification and annotation of 3' UTR ends using RNA-seq data

DESCRIPTION (provided by applicant): When a gene is activated, it is copied (transcribed) from DNA into a string of molecules called a messenger RNA (mRNA). The middle section of each mRNA encodes the information that is translated into the corresponding protein sequence; the two ends, called untranslated regions (UTRs), play a number of other important roles. This proposal concerns the tail end of the mRNA, known as the 3' UTR, which helps to regulate the stability and location of the mRNA and the amount of the corresponding protein that is produced. The point at which the transcription of a given mRNA ends is determined by the presence of a sequence called a polyadenylation site. Some genes have more than one such site, meaning that there can be two or more different forms of the corresponding mRNA, with different 3' UTRs and therefore different levels of activity. Changes in the ratio of the different forms are thought to contribute to the development of a range of disorders, including some cancers. The methods currently used to study polyadenylation require an extra set of experiments to be run, which is expensive and slow. However, Drs. Birol and Karsan and their teams have obtained evidence that polyadenylation can be studied alongside other important types of transcriptional regulation, using data from experiments that are already performed as part of standard analysis. This will make studies of polyadenylation sites affordable by more laboratories, and will add value to existing data.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R21
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
    93565
  • Indirect Cost Amount
    7485
  • Total Cost
    101050
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    396
  • Ed Inst. Type
  • Funding ICs
    NCI:101050\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZCA1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BRITISH COLUMBIA CANCER AGENCY
  • Organization Department
  • Organization DUNS
    209137736
  • Organization City
    VANCOUVER
  • Organization State
    BC
  • Organization Country
    CANADA
  • Organization Zip Code
    V5Z 1L3
  • Organization District
    CANADA